144 related articles for article (PubMed ID: 1311687)
41. Agonist-induced phosphoinositide hydrolysis in choroid plexus.
Conn PJ; Sanders-Bush E
J Neurochem; 1986 Dec; 47(6):1754-60. PubMed ID: 3021903
[TBL] [Abstract][Full Text] [Related]
42. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
43. Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.
Kuoppamäki M; Syvälahti E; Hietala J
Eur J Pharmacol; 1993 Apr; 245(2):179-82. PubMed ID: 8387927
[TBL] [Abstract][Full Text] [Related]
44. Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP).
Kłodzińska A; Jaros T; Chojnacka-Wójcik E; Maj J
J Neural Transm Park Dis Dement Sect; 1989; 1(3):207-18. PubMed ID: 2775468
[TBL] [Abstract][Full Text] [Related]
45. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
Chaouloff F; Laude D; Baudrie V
Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
[TBL] [Abstract][Full Text] [Related]
46. Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.
Edwards E; Harkins K; Ashby CR; Wang RY
J Pharmacol Exp Ther; 1991 Mar; 256(3):1025-32. PubMed ID: 1848625
[TBL] [Abstract][Full Text] [Related]
47. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in the mouse cortex has pharmacological characteristics compatible with mediation via 5-HT2 receptors but this response does not reflect altered 5-HT2 function after 5,7-dihydroxytryptamine lesioning or repeated antidepressant treatments.
Godfrey PP; McClue SJ; Young MM; Heal DJ
J Neurochem; 1988 Mar; 50(3):730-8. PubMed ID: 2828545
[TBL] [Abstract][Full Text] [Related]
48. 5-HT1A receptor agonists inhibit carbachol-induced stimulation of phosphoinositide turnover in the rat hippocampus.
Claustre Y; Bénavidès J; Scatton B
Eur J Pharmacol; 1988 Apr; 149(1-2):149-53. PubMed ID: 2840296
[TBL] [Abstract][Full Text] [Related]
49. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
[TBL] [Abstract][Full Text] [Related]
50. A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
Choudhary MS; Craigo S; Roth BL
Mol Pharmacol; 1993 May; 43(5):755-61. PubMed ID: 8388989
[TBL] [Abstract][Full Text] [Related]
51. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
Kennett GA; Curzon G
Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
[TBL] [Abstract][Full Text] [Related]
52. Effect of electroconvulsive shock on 5-HT2 and alpha 1-adrenoceptors and phosphoinositide signalling system in rat brain.
Pandey GN; Pandey SC; Isaac L; Davis JM
Eur J Pharmacol; 1992 Aug; 226(4):303-10. PubMed ID: 1327845
[TBL] [Abstract][Full Text] [Related]
53. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
Berendsen HH; Broekkamp CL
Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
[TBL] [Abstract][Full Text] [Related]
54. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
J Pharmacol Exp Ther; 1993 Mar; 264(3):1262-7. PubMed ID: 8383744
[TBL] [Abstract][Full Text] [Related]
55. Denervation supersensitivity of 5-HT-1c receptors in rat choroid plexus.
Conn PJ; Janowsky A; Sanders-Bush E
Brain Res; 1987 Jan; 400(2):396-8. PubMed ID: 3815085
[TBL] [Abstract][Full Text] [Related]
56. Regulation of serotonin 5-HT2C receptors in the rat choroid plexus after acute clozapine treatment.
Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
Eur J Pharmacol; 1994 Oct; 269(2):201-8. PubMed ID: 7851496
[TBL] [Abstract][Full Text] [Related]
57. Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain.
Undie AS; Friedman E
Eur J Pharmacol; 1992 Aug; 226(4):297-302. PubMed ID: 1327844
[TBL] [Abstract][Full Text] [Related]
58. Biochemical characterization of the mechanisms involved in the 5-hydroxytryptamine-induced increase in rat atrial rate.
el Rawadi C; Davy M; Midol-Monnet M; Cohen Y
Biochem Pharmacol; 1994 Aug; 48(4):683-8. PubMed ID: 7915903
[TBL] [Abstract][Full Text] [Related]
59. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.
Pazos A; Hoyer D; Palacios JM
Eur J Pharmacol; 1984 Nov; 106(3):539-46. PubMed ID: 6519175
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
Hamel E; Robert JP; Young AR; MacKenzie ET
J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
